A Potential Drug for Blocking HIV (IMAGE)
Caption
D-peptide inhibitors (PIE12, yellow) bind to the HIV "pocket" region (orange). PIE12 binds to the pocket, preventing interaction of other HIV components required to mediate HIV's entry into target cells. University of Utah associate professor of biochemistry Michael S. Kay, M.D., Ph.D., hopes to begin human trials of a PIE12-based drug in two to three years.
Credit
Michael S. Kay, M.D., Ph.D., University of Utah School of Medicine.
Usage Restrictions
Can only be used for public dissemination in newspapers, magazines, or on television. Photo must be credited to Michael S. Kay.
License
Licensed content